Compound+1-57 - Compound Search

Thiamiprine; 1H-Purin-2-amine, 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- (9CI); Purine, 2-amino-6- CAS 5581-52-2 PubChem CID 3379405

Cn1cnc([N+](=O)[O-])c1Sc1nc(N)nc2nc[nH]c12

Synthesis of (R)-(3-aminopiperidin-1-yl)(3-methyl-2-(1-(pyrazin-2-ylmethyl)-1H-indol-2-yl)imidazo[1,2 PubChem CID 138578703

Cc1c(-c2cc3ccccc3n2Cc2cnccn2)nc2cc(C(=O)N3CCC[C@@H](NC(=O)OC(C)(C)C)C3)ccn12

US9688684, Compound 57: 8-(3-Isopropyl-1-phenyl-1H-pyrazol-4-yl)-7-(3-methyl-benzyl)-5,6,7,8-tetrahydro-tetrazolo PubChem CID 118169464

Cc1cccc(CN2CCn3nnnc3C2c2cn(-c3ccccc3)nc2C(C)C)c1

Synthesis of N-(5-((1-ethylpiperidin-4-yl)methoxy)pyridin-2-yl)-5-fluoro-4-(5-fluoro-1,1-dimethyl-2,3 PubChem CID 137513620

CCN1CCC(COc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc6n(c5c4)C(C)(C)CC6)n3)nc2)CC1

US11691962, Compound 1-57 PubChem CID 139402889

CC(C)[C@@H](NC(=O)N1C(=O)[C@H](Cc2ccnc(N)c2)[C@H]1C(=O)N(C)c1ccn(C)n1)C1CCCCC1

US12435061, Compound 1-57 PubChem CID 156815037

N#Cc1cc(C(F)(F)F)ccc1N1CC[C@H](Oc2ccc(C(F)(F)F)cn2)C1

WO2022098806, Compound 1-57 PubChem CID 163290991

COc1cc2c(cc1Nc1ncc3ccc(-c4ccc(CN(C)C)cc4)cc3n1)CNCC2

US20230365541, Compound 57, isomer 1 PubChem CID 169551840

CSC1=CC(C)=NC(=O)C1CNC(=O)c1cc(Cl)c2c(c1C)OC(C)(C1CCC(CN3CCOCC3)CC1)O2

1 3 5-Triazine-2 4 6-triamine compd. with 1 3 5-triazine-2 4 6(1H 3H 5H)-trione (1:1) (9CI) CAS 37640-57-6 PubChem CID 93198

Nc1nc(N)nc(N)n1.O=c1[nH]c(=O)[nH]c(=O)[nH]1

CCCCCCCCCCCCCCCC[N+](C)(C)C.[Br-]

4,7-Methano-1H-indene, 1,2,4,5,6,7,8,8-octachloro-2,3,3a,4,7,7a-hexahydro-, (1.alpha.,2.alpha.,3a.alpha.,4.beta.,7.beta.,7a.alpha.)- CAS 12789-03-6 PubChem CID 5993

ClC1=C(Cl)C2(Cl)C3C(Cl)C(Cl)CC3C1(Cl)C2(Cl)Cl

Benzeneethanamine, 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-, hydrochloride (1:1); 2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine Hydrochloride; 2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxybenzyl)]ethylamine hydrochloride; 25B-NBOMe HCl; 2C-B-NBOMe HCl CAS 1539266-15-3 PubChem CID 76965389

COc1cc(CCNCc2ccccc2OC)c(OC)cc1Br.Cl

Rufinamide Impurity 1 pound>>4-Descarboxamido Rufinamide 4-Methyl Ester pound>>Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate CAS 217448-86-7 PubChem CID 22716778

COC(=O)c1cn(Cc2c(F)cccc2F)nn1

Stavudine Imp. A (EP); Zidovudine Imp. C (EP); Zidovudine USP Related Compound C; Zidovudine USP RC C; Thymine; 5-Methylpyrimidine-2,4(1H,3H)-dione; USP Zidovudine Related Compound C; Ph Eur Zidovudine Impurity C; Thymine; Zidovudine Related Compound C; Stavudine Impurity A; Zidovudine Impurity C CAS 65-71-4 PubChem CID 1135

Cc1c[nH]c(=O)[nH]c1=O

(S)-2-Amino-5-guanidinopentanoic Acid Compound With (S)-2-Aminopentanedioic Acid (1:1); L-Arginine, L-glutamate (1:1); Argimate; Arginine Glutamate; Ginamate; Glutamic Acid Compd. With Arginine; Glutargin; Glutepar; Modumate; NSC 122009; NSC 164937; CAS 4320-30-3 PubChem CID 165268

NC(N)=NCCC[C@H](N)C(=O)O.N[C@@H](CCC(=O)O)C(=O)O

(2E)-2-(1-methyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazinecarbothioamide CAS 1910-68-5 PubChem CID 667492

Cn1c(O)c(N=NC(N)=S)c2ccccc21

(1S,3aS,3bR,7S,9aR,9bS,11R,11aS)-1-acetyl-7-{[(2R,4S,5R,6R)-5-{[(2S,4S,5R,6R)-5-{[(2S,3R,4S,5R,6R)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-3a-hydroxy-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-11-yl (2E)-2-methylbut-2-enoate CAS 384329-61-7 PubChem CID 9962786

C/C=C(\C)C(=O)O[C@@H]1C[C@H]2[C@@H](CC=C3C[C@@H](O[C@H]4C[C@H](OC)[C@H](O[C@H]5C[C@H](OC)[C@H](O[C@@H]6O[C@H](C)[C@@H](O)[C@H](OC)[C@H]6O)[C@@H](C)O5)[C@@H](C)O4)CC[C@@]32C)[C@@]2(O)CC[C@H](C(C)=O)[C@@]12C

Physostigmine salicylate; (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate salicylate; Benzoic acid, 2-hydroxy-, compd. with (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1) (9CI); Benzoic acid, 2-hydroxy-, compd. with (3aS-cis)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1); Physostigmine salicylate (6CI); Physostigmine, monosalicylate (8CI); Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS,8aR)-, mono(2-hydroxybenzoate) (salt) (9CI); Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-, mono(2-hydroxybenzoate) (salt); Salicylic acid, compd. with physostigmine (1:1) (8CI); (-)-Physostigmine salicylate; Eserine salicylate; Isopto Eserine CAS 57-64-7 PubChem CID 657348

CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C.O=C(O)c1ccccc1O

DL-Tryptophan, N-(1-oxo-9-octadecenyl)-, ethyl ester, (Z)- CAS 71806-22-9 PubChem CID 53471066

CCCCCCCC/C=C\CCCCCCCC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)OCC

Fenofibrate Imp. A (EP); Fenofibrate USP Related Compound A; Fenofibrate USP RC A; (4-Chlorophenyl)(4-hydroxyphenyl)methanone; Fenofibrate Related Compound A; Fenofibrate Impurity A CAS 42019-78-3 PubChem CID 123504

O=C(c1ccc(O)cc1)c1ccc(Cl)cc1

Compound Database